I am 74 and in CLL remission after a 24-month course of Venetoclax plus Rituximab completed in September 2023.
In July 2023 I was diagnosed with low grade, non-muscle invasive (PTa) bladder cancer and had a 12-month treatment with Epirubicin per respective protocol. Although biopsies at 3-month intervals during the 12-nonth treatment came out clean, the last one done two weeks ago showed recurrence of low grade, non-muscle invasive (PTa) bladder cancer. It seems that the most effective treatment would now be with BCG, which however is not recommended for people with CLL. I am due to see my hematologist this Wednesday to discuss the situation.
Meanwhile I wonder whether any of you has faced this dilemma and his/her experience or advice in this respect.
Many thanks!
Ramses